BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
At least 7 dead as Israel renews attacks on Beirut and across Lebanon - 2Launch pad damaged as Russian rocket blasts off for space station, agency says
- 3Vote in favor of your Favored kind of craftsmanship
- 4Reporter's notebook: Inside the IDF’s ‘Hamas Village,’ and how Israel is rewriting urban warfare
- 5State asks High Court to reject challenge to anti-UNRWA laws ahead of Monday hearing
- A hunger for new experiences Narratives: Motivating Travel and Experience
- Germany raises prospect of military forces to secure Ukraine peace
- Portugal among EU countries with the most people working close to 50 hours a week
- Doulas play essential roles in reproductive health care – and more states are beginning to recognize it
- The breakout star of NASA's Artemis 2 moon mission isn't an astronaut — it's the space toilet
- This cafe takes orders in sign language. It's cherished by the Deaf community
- Figure out How to Remain Informed about the Most recent Open Record Extra Offers
- Swap The Amalfi Coast For This Low-Cost Ligurian Seaside Town
- Looter indicted after pretending to be emergency worker at Dimona rocket crash site
